Attach to Form 990 or Form 990-EZ.
Go to
www.irs.gov/Form990 for instructions and the latest information.
| (i) Name of supported organization | (ii) EIN | (iii) Type of organization (described on lines 1- 10 above (see instructions)) | (iv) Is the organization listed in your governing document? | (v) Amount of monetary support (see instructions) | (vi) Amount of other support (see instructions) | |
|---|---|---|---|---|---|---|
| Yes | No | |||||
|
Total |
||||||
Calendar year
(or fiscal year beginning in)
![]() |
(a) 2018 | (b) 2019 | (c) 2020 | (d) 2021 | (e) 2022 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grant.") .. | ||||||
| 2 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf.... | ||||||
| 3 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | ||||||
| 4 | Total. Add lines 1 through 3 | ||||||
| 5 | The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f) .. | ||||||
| 6 | Public support. Subtract line 5 from line 4. | ||||||
Calendar year
(or fiscal year beginning in)
![]() |
(a) 2018 | (b) 2019 | (c) 2020 | (d) 2021 | (e) 2022 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 7 | Amounts from line 4.. | ||||||
| 8 | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources... | ||||||
| 9 | Net income from unrelated business activities, whether or not the business is regularly carried on.. | ||||||
| 10 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.).. | ||||||
| 11 | Total support. Add lines 7 through 10 | ||||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2018 | (b) 2019 | (c) 2020 | (d) 2021 | (e) 2022 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") . | ||||||
| 2 | Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose | ||||||
| 3 | Gross receipts from activities that are not an unrelated trade or business under section 513 ..... | ||||||
| 4 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf... | ||||||
| 5 | The value of services or facilities furnished by a governmental unit to the organization without charge | ||||||
| 6 | Total. Add lines 1 through 5 | ||||||
| 7a | Amounts included on lines 1, 2, and 3 received from disqualified persons | ||||||
| b | Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year. | ||||||
| c | Add lines 7a and 7b.. | ||||||
| 8 | Public support. (Subtract line 7c from line 6.) | ||||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2018 | (b) 2019 | (c) 2020 | (d) 2021 | (e) 2022 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 9 | Amounts from line 6... | ||||||
| 10a | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources.. | ||||||
| b | Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975. | ||||||
| c | Add lines 10a and 10b. | ||||||
| 11 | Net income from unrelated business activities not included on line 10b, whether or not the business is regularly carried on. | ||||||
| 12 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) .. | ||||||
| 13 | Total support. (Add lines 9, 10c, 11, and 12.).. | ||||||
| Section A - Adjusted Net Income | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Net short-term capital gain | 1 | ||||
| 2 | Recoveries of prior-year distributions | 2 | ||||
| 3 | Other gross income (see instructions) | 3 | ||||
| 4 | Add lines 1 through 3 | 4 | ||||
| 5 | Depreciation and depletion | 5 | ||||
| 6 | Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions) | 6 | ||||
| 7 | Other expenses (see instructions) | 7 | ||||
| 8 | Adjusted Net Income (subtract lines 5, 6 and 7 from line 4) | 8 | ||||
| Section B - Minimum Asset Amount | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year): | 1 | ||||
| a | Average monthly value of securities | 1a | ||||
| b | Average monthly cash balances | 1b | ||||
| c | Fair market value of other non-exempt-use assets | 1c | ||||
| d | Total (add lines 1a, 1b, and 1c) | 1d | ||||
| e |
Discount claimed for blockage or other factors (explain in detail in Part VI): |
|||||
| 2 | Acquisition indebtedness applicable to non-exempt use assets | 2 | ||||
| 3 | Subtract line 2 from line 1d | 3 | ||||
| 4 | Cash deemed held for exempt use. Enter 0.015 of line 3 (for greater amount, see instructions). | 4 | ||||
| 5 | Net value of non-exempt-use assets (subtract line 4 from line 3) | 5 | ||||
| 6 | Multiply line 5 by 0.035 | 6 | ||||
| 7 | Recoveries of prior-year distributions | 7 | ||||
| 8 | Minimum Asset Amount (add line 7 to line 6) | 8 | ||||
| Section C - Distributable Amount | Current Year | |||||
| 1 | Adjusted net income for prior year (from Section A, line 8, Column A) | 1 | ||||
| 2 | Enter 85% of line 1 | 2 | ||||
| 3 | Minimum asset amount for prior year (from Section B, line 8, Column A) | 3 | ||||
| 4 | Enter greater of line 2 or line 3 | 4 | ||||
| 5 | Income tax imposed in prior year | 5 | ||||
| 6 | Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions) | 6 | ||||
| Section D - Distributions | Current Year | |
|---|---|---|
| 1 Amounts paid to supported organizations to accomplish exempt purposes | 1 | |
|
2
Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in excess of income from activity |
2 | |
| 3 Administrative expenses paid to accomplish exempt purposes of supported organizations | 3 | |
| 4 Amounts paid to acquire exempt-use assets | 4 | |
| 5 Qualified set-aside amounts (prior IRS approval required - provide details in Part VI) | 5 | |
| 6 Other distributions (describe in Part VI). See instructions | 6 | |
| 7Total annual distributions. Add lines 1 through 6. | 7 | |
|
8
Distributions to attentive supported organizations to which the organization is responsive (provide details in Part VI). See instructions |
8 | |
| 9 Distributable amount for 2022 from Section C, line 6 | 9 | |
| 10 Line 8 amount divided by Line 9 amount | 10 | |
| Section E - Distribution Allocations (see instructions) |
(i) Excess Distributions |
(ii) Underdistributions Pre-2022 |
(iii) Distributable Amount for 2022 |
|
|---|---|---|---|---|
| 1 Distributable amount for 2022 from Section C, line 6 | ||||
|
2
Underdistributions, if any, for years prior to 2022 (reasonable cause required-- explain in Part VI).
See instructions. |
||||
| 3 Excess distributions carryover, if any, to 2022: | ||||
| a From 2017....... | ||||
| b From 2018....... | ||||
| c From 2019....... | ||||
| d From 2020....... | ||||
| e From 2021....... | ||||
| fTotal of lines 3a through e | ||||
| g Applied to underdistributions of prior years | ||||
| h Applied to 2022 distributable amount | ||||
|
i
Carryover from 2017 not applied (see instructions) |
||||
| j Remainder. Subtract lines 3g, 3h, and 3i from line 3f. | ||||
| 4Distributions for 2022 from Section D, line 7: | ||||
| $ | ||||
| a Applied to underdistributions of prior years | ||||
| b Applied to 2022 distributable amount | ||||
| c Remainder. Subtract lines 4a and 4b from line 4. | ||||
|
5
Remaining underdistributions for years prior to 2022, if any. Subtract lines 3g and 4a from line 2. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
6
Remaining underdistributions for 2022. Subtract lines 3h and 4b from line 1. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
7 Excess distributions carryover to 2023. Add lines 3j and 4c. |
||||
| 8 Breakdown of line 7: | ||||
| a Excess from 2018..... | ||||
| b Excess from 2019..... | ||||
| c Excess from 2020..... | ||||
| d Excess from 2021..... | ||||
| e Excess from 2022..... | ||||
| Facts And Circumstances Test |
|---|
| Return Reference | Explanation |
|---|
| Software ID: | |
| Software Version: |
Attach to Form 990 or 990-EZ.
Go to www.irs.gov/Form990 for the latest information.
| Return Reference | Explanation |
|---|---|
| PART 1, LINE 1, REVENUE, SEE BELOW: | DONOR DIRECTED CONTRIBUTION FROM EARL E AND PHYLLIS G NICHOLS TRUST |
| PART I, LINE1, REVENUE CHANGES, CONTINUED: | PDRIOR TO THE PANDEMIC, TESTICULAR CANCER COMMONS (TCC) WAS ABLE TO ACCRUE UNSPENT RAINY DAY FUNDS THROUGH ACCUMULATION OF INCIRECT COSTS FROM TWO SOURCES. |
| PART I, LINE1 REVENUE CHANGES, CONTINUED: | DR NICHOLS WAS ELECTED AS TREASURER AND A MEMBER OF THE EXECUTIVE COMMITTEE FOR THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) |
| PART 1, REVENUE CHANGES, CONTINUED | AS PARTIAL COMPENSATION FOR THE TIME CONTRIBUTED TO BOARD AND OTHER ACTIVITIES, ANNUAL GRANTS WERE GIVEN TO TCC AVERAGING $50,000 TO $60,000 ANNUALLY |
| PART 1, REVENUE CHANGES, CONTINUED: | TCC ACCRUED INDIRECT COSTS AND PASSED SOME THROUGH TO DR. NICHOLS AS MONETARY COMPENSATION FOR THE SIGNIFICANT TIME COMMITMENT AWAY FROM TCC, HIS PRIMARY INSTITUTION. |
| PART 1, REVENUE CHANGES, CONTINUED: | FOR SOME YEARS, TCC WAS ABLE TO RUN POSITIVE BALANCES THROUGH THE ASCO DONATIONS AND INDIRECT COST ACCRUAL FROM OTHER FEDERAL SCIENTIFIC GRANTS. |
| PART I, REVENUE CHANGES, CONTINUED: | THIS ALL CHANGED MARKEDLY IN EARLY 2020 WITH THE COVID-19 PANDEMIC WHICH PROFOUNDLY CHANGED THE BUSINESS BODEL AND WORK FLOW OF TCC. |
| PART 1, REVENUE CHANGES, CONTINUED: | AT THAT TIME, DR. NICHOLS' ASCO TERM HAD BEEN COMPLETED AND ASCO GRANTS DISCONTINUED. |
| PART 1, REVENUE CHANGES, CONTINUED: | HIS SWOG TENURE ENDED AND THE BUSINESS MODEL CHANGED FROM LARGELY A FACE TO FACE BUSINESS TO THE TELEHEALTH MODEL. |
| PART1, REVENUE CHANGES, CONTINUED: | CONCURRENT WITH THE PANDEMIC AND DECLINING REVENUE, TCC WAS FORCED TO PIVOT TO AN ADMINISTRATIVE ONLY MODEL OF BUSINESS TO PROVIDE THE INFRASTRUCTURE WHICH FULLY TRANSPIRED IN 2022 |
| PART1, REVENUE CHANGES, CONTINUED: | AS WELL, FOR REASON OF PROXIMITY TO VANDERBILT UNIVERISTY AND UNIFORMED SERVICES UNIVERSITY (BETHESDA), TCC OFFICES REQUIRED RELOCATION TO KNOXVILLE, TN |
| PART 1, REVENUE CHANGES, CONTINUED: | TCC INVESTED IN FULL TELEHEALTH CAPABILITIES TO ACCOMODATE THE CURRENT WORK MODEL AND PRIMARY GRANT RELATIONSHIPS. |
| PART 1, REVENUE CHANGES, CONTINUED: | PRODUCTIVITY IN TERMS OF GRANTS AND PUBLICATIONS AND, MOST IMPORTANTLY, FAVORABLE PATIENT IMPACT IN TERMS OF REDUCTION OF NEED FOR CHEMOTHERAPY AND REDUCTION IN LATE TREATMENT EFFECTS IS APPROACHING |
| PART1, REVENUE CHANGES, CONTINUED: | A PEAK WITH THE INTERIM ANALYSIS OF 956 PATIENTS ON THE NORTH AMERICAN CLINICAL TRANSLATIONAL STUDY-S1823/CCTG GCC1 BEGINNING IN EARLY 2024 |
| PART1, REVENUE CHANGES, CONTINUED: | IN EARLY 2023 AND GOING FORWARD, TCC WILL OPERATE ON A BUDGET OF AROUND $20,000 WITH NO DIRECT COMPENSATION OF ANY OFFICERS OR DR. NICHOLS |
| PART1, REVENUE CHANGES, CONTINUED: | THE 2022 CHANGES IN FUND BALANCES AND NET ASSETS REFLECT THE WINDING DOWN OF DIRECT COMPENSATION TO DR. NICHOLS AND THE INVESTMENT IN NEW SPACE AND TELEHEALTH INFRASTRUCTURE |
| PART1, REVENUE CHANGES, CONTINUED: | (ADOBE, OFFICE, ZOOM, QUICKBOOK SUBSCRIPTIONS, BUSINESS INTERNET, COMPUTERS, MONITORS, PRINTERS, NETWORK SOFTWARE AND HARDWARE AND SOM TRAVEL TO DC AND BRITISH COLUMBIA |
| PART 1, REVENUE CHANGES, CONTINUED: | THIS INVESTMENT LARGELY CAME FROM UNSPENT ACCRRUED FUNDS FROM PRIOR YEARS |
| PART III, PRIMARY EXEMPT PURPOSE | TESTICULAR CANCER COMMONS (TCC) IS A 501(C)(3) ESTABLISHED IN 2012 WITH THE MISSION OF EXCHANGE OF SCIENTIFIC AND CLINICAL INFORMATION AND KNOWLEDGE FOR PATIENTS, FAMILIES AND MEDICAL PROFESSIONS EXPERIENCING OR MANAGING TESTICULAR GERM CELL CANCER. OVER THE LAST DECADE, TCC HAS BECOME A MAJOR CONTENT PRODUCER IN THE FIELD AND IS A LEADER IN NOT ONLY GENERATION OF NEW KNOWLEDGE, BUT A LEAD INSTITUTION IN KNOWLEDGE IMPLEMENTATION AND DISSEMINATION. FROM AN ADMINISTRATIVE AND SUPPORT STANDPOINT, TCC HAS BEEN FORTUNATE IN THAT WE HAVE NOT YET HAD TO TURN TO PUBLIC FUND RAISING AND HAS BEEN SUPPORTED BY WRITING AND RECEIVING PEER REVIEWED GRANTS, GENEROUS SUPPORT FOR ADMINISTRATIVE FUNCTIONS USING DONOR DIRECTED FUNDS FROM THE EARL E AND PHYLLIS G NICHOLS TRUST THROUGH THE LUTHERAN CHURCH MISSOURI SYNOD FOUNDATION AND THROUGH IN-KIND AND DIRECT FINANCIAL SUPPORT FROM FOUNDER AND DIRECTOR DR. CRAIG NICHOLS. TCC IS FORTUNATE TO HAVE SAGE GOVERNANCE THROUGHT THE ENGAGEMENT OF OUR 5 PHYSICIANS/SCIENTISTS BOARD. AS OF 2022, TCC NO LONGER PAYS DIRECT SALARIES AND SUPPORT IS NOW DIRECTED TOWARD ADMINISTRATIVE SUPPORT ONLY GOING FORWARD |
| PART III, ACHIEVEMENTS | TCC PRODUCTIVITY 2021-2023. PUBLICATIONS IN HIGH IMPACT JOURNALS: |
| PART III, ACHIEVEMENTS (PUBLICATIONS) 1. | 1. NAPPI L SAXTENA N MAZUREK S ET AL. LONGITUDINAL EVALUATION OF PLASMA MIR371 TO DETEC MIMINAL RESIDUAL DISEASE AND EARLY RELAPSE IN GERM CELL MALIGANCIES (CURRENTLY UNDER SECOND LEVEL PEER REVIEW) |
| PART III, ACHIEVEMENTS (PUBLICATIONS) 2. | NAPPI L, THI M, ADRA N, ET AL INTEGRATED EXPRESSION OF CIRCULATING MIR375 AND MIR 371 TO IDENTIFY TERATOMA AND ACTIVE GERM CELL MALIGNANCY COMPONENTS IN MALIGNANT GERM CELL TUMORS EUR UROL 2021 JAN; 79(1): 16-19 |
| PART III, ACHIEVEMENTS (PUBLICATIONS) 3. | DANESHMAND S, CARY C, MSATERSON T ET AL SURGERY IN EARLY METASTATIC SEMINOMA (SEMS): A PHASE II TRIA OF RETROPERITONEAL LYMPH NODE DISSECTION FOR TESTICULAR SEMINOMA WITH LIMITED RETROPERITONEAL LYMPHADENOPATHY. J CLIN ONCOL 2023 ACCEOTED FIR OYBKUCATUIB |
| PART III, ACHIEVEMENTS (PEER REVIEWED GRANTS WRITTEN 2022/2023 | R01 (R37) - IMAGING, BIOMARKERS AND DIGITAL PATHOMICS FOR THE EARLY DETECTION OF PREMETASTATIC AGGRESSIVE CANCER. NATIONAL INSTITUE OF HEALTH 05/03/2022 - 05/09/22025 NAPPI L PI FUNDED WITH POSSIBLE MERIT EXTENSION. DOD TRANSLATIONAL TEAM SCIENCE AWARD (TTSA) BUILDING A PERSONALIZED, POPULATION-LEVE; ATIENT-ORIENTED TRANSLATIONAL RESEARCH AND CANCER CARE DELIVERY PLATFORM FOR GERM CELL CANCER WITHIN THE ACTIVE MILITARY HEALTH CARE SYSTEM (SCORED BUT NOT FUNDED). R-13 NIH GERM CELL TUMOR WELLSPRONG CONFERENCE (START DATE 7-23) SCORED BUT NOT FUNDED). PEER REVIEWED CANCER RESEARCH PROGRAM DOD IMPACT AWARD SCHEDULED SUBMISSION 7-23 CURRENTLY UNDER SCIENTIFIC REVIEW. PEER REVIEWED CANCER RESEARCH PROGRAM DOD PATIENT WELL BEING AND SURVIVORSHIP AWARD SUBMISSION 8-2023 UNDER SCIENTIFIC REVIEW. R-37 MERIT EXTENSION (NAPPI) SUBMISSION 10-2023 UNDER SCIENTIFIC REVIEW. |
| Software ID: | |
| Software Version: |
| Person Name | Explanation |
|---|---|
| CRAIG R NICHOLS MD | SERVICES PERFORMED AS FOUNDER / DIRECTOR |